Generics Pharmaceuticals: STI is committed to delivering high-quality and affordable generic pharmaceuticals. In addition to the currently marketed products, STI is developing a pipeline of generic products that will be accessible to health care providers and patients in the future.
Proprietary Pharmaceuticals: We develop and acquire proprietary niche products. Our product offerings will include products utilizing alternative delivery technologies and other new dosage forms. With our highly experienced staff we can bring these products to market faster and more efficiently.
All our current and future products are and will be FDA approved and manufactured in FDA approved facilities which comply with all regulatory requirements for manufacturing and distribution of pharmaceutical products.
Offices in United States: